AlphaStocks
7.2
Consider Buy

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Health Care

ADR

$30.23

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#76out of 1127 in Health Care

Is TEVA PHARMACEUTICAL INDUSTRIES LTD a Good Investment in 2026?

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) scores 7.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates TEVA PHARMACEUTICAL INDUSTRIES LTD as Strong. However, the Graham model rates it Caution — Significantly above fair value. TEVA PHARMACEUTICAL INDUSTRIES LTD currently trades below its estimated fair value of $42, suggesting potential upside. TEVA PHARMACEUTICAL INDUSTRIES LTD ranks #76 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.9ROE17.8Market Cap35B

Estimated Fair Value

$42.4129% below

Fair value above market price. P/E of 25x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Strong

Top 10% (rank 7%)

Frequently Asked Questions

Is TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) a good investment?
Based on AlphaStocks' composite analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) scores 7.2 out of 10, earning a Consider Buy rating. This places it above average across most investment dimensions. Fair value above market price. P/E of 25x is moderate for this quality level.
What is TEVA PHARMACEUTICAL INDUSTRIES LTD's Piotroski F-Score?
TEVA PHARMACEUTICAL INDUSTRIES LTD's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is TEVA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $42, TEVA appears undervalued. The stock currently trades 29% below its estimated fair value. Fair value above market price. P/E of 25x is moderate for this quality level.
How does TEVA compare to other Health Care stocks?
TEVA PHARMACEUTICAL INDUSTRIES LTD ranks #76 out of 1127 stocks in the Health Care sector, placing it in the top 7% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about TEVA?
AlphaStocks evaluates TEVA using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 7.2/10.

Similar Stocks

PARRFTIAZN

Compare TEVA with

TEVA vs PARRTEVA vs FTITEVA vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer